These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15486377)

  • 41. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast.
    Pearlman DS; van Adelsberg J; Philip G; Tilles SA; Busse W; Hendeles L; Loeys T; Dass SB; Reiss TF
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):98-104. PubMed ID: 16892789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval.
    Bronsky EA; Kemp JP; Zhang J; Guerreiro D; Reiss TF
    Clin Pharmacol Ther; 1997 Nov; 62(5):556-61. PubMed ID: 9390112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can a single dose response predict the effect of montelukast on exercise-induced bronchoconstriction?
    Kersten ET; Akkerman-Nijland AM; Driessen JM; Diamant Z; Thio BJ
    Pediatr Pulmonol; 2016 May; 51(5):470-7. PubMed ID: 26492292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Onset and duration of attenuation of exercise-induced bronchoconstriction in children by single-dose of montelukast.
    Wasfi YS; Kemp JP; Villarán C; Massaad R; Xin W; Smugar SS; Knorr BA; Philip G
    Allergy Asthma Proc; 2011; 32(6):453-9. PubMed ID: 22221440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of inhaled bronchodilators on lung function and cycling performance in female athletes with and without exercise-induced bronchoconstriction.
    Koch S; Karacabeyli D; Galts C; MacInnis MJ; Sporer BC; Koehle MS
    J Sci Med Sport; 2015 Sep; 18(5):607-12. PubMed ID: 25156879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD; Stanford R; Crim C; Yancey SW; Edwards L; Rickard KA; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast.
    Camargo CA; Boulet LP; Sutherland ER; Busse WW; Yancey SW; Emmett AH; Ortega HG; Ferro TJ
    J Asthma; 2010 Feb; 47(1):76-82. PubMed ID: 20100025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction.
    Vidal C; Fernández-Ovide E; Piñeiro J; Nuñez R; González-Quintela A
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):655-8. PubMed ID: 11428738
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
    van der Woude HJ; Boorsma M; Bergqvist PB; Winter TH; Aalbers R
    Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Single dose of montelukast as an effective prevention of post exercise bronchospasm in children with bronchial asthma].
    Gaszczyk G; Latoś T; Słowikowski A; Janiak B
    Med Wieku Rozwoj; 2004; 8(3 Pt 2):847-56. PubMed ID: 15858257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
    Nelson HS; Busse WW; Kerwin E; Church N; Emmett A; Rickard K; Knobil K
    J Allergy Clin Immunol; 2000 Dec; 106(6):1088-95. PubMed ID: 11112891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does single dose salmeterol affect exercise capacity in asthmatic men?
    Robertson W; Simkins J; O'Hickey SP; Freeman S; Cayton RM
    Eur Respir J; 1994 Nov; 7(11):1978-84. PubMed ID: 7875268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pulmonary gas exchange response to exercise- and mannitol-induced bronchoconstriction in mild asthma.
    Muñoz PA; Gómez FP; Manrique HA; Roca J; Barberà JA; Young IH; Anderson SD; Rodríguez-Roisin R
    J Appl Physiol (1985); 2008 Nov; 105(5):1477-85. PubMed ID: 18756011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD.
    O'Donnell DE; Sciurba F; Celli B; Mahler DA; Webb KA; Kalberg CJ; Knobil K
    Chest; 2006 Sep; 130(3):647-56. PubMed ID: 16963658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children.
    de Benedictis FM; del Giudice MM; Forenza N; Decimo F; de Benedictis D; Capristo A
    Eur Respir J; 2006 Aug; 28(2):291-5. PubMed ID: 16641126
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of exercise-induced bronchospasm in pediatric asthma patients: A comparison of two salmeterol powder delivery devices.
    Bronsky EA; Pearlman DS; Pobiner BF; Scott C; Wang Y; Stahl E
    Pediatrics; 1999 Sep; 104(3 Pt 1):501-6. PubMed ID: 10469776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma.
    Stelmach I; Grzelewski T; Majak P; Jerzynska J; Stelmach W; Kuna P
    J Allergy Clin Immunol; 2008 Feb; 121(2):383-9. PubMed ID: 17980416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of exercise induced asthma by inhaled salmeterol xinafoate.
    Green CP; Price JF
    Arch Dis Child; 1992 Aug; 67(8):1014-7. PubMed ID: 1355645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
    Carlsen KH; Hem E; Stensrud T; Held T; Herland K; Mowinckel P
    Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.